Joseph Ciaffoni - 22 Dec 2022 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role
President and CEO, Director
Signature
/s/ Colleen Tupper as Attorney-In-Fact For Joseph Ciaffoni
Issuer symbol
COLL
Transactions as of
22 Dec 2022
Net transactions value
-$58,252
Form type
4
Filing time
27 Dec 2022, 18:16:43 UTC
Previous filing
21 Dec 2022
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Sale $2,530 -110 -0.04% $23.00 251,101 22 Dec 2022 Direct F1
transaction COLL Common Stock Sale $3,381 -147 -0.06% $23.00 250,954 23 Dec 2022 Direct F1, F2
transaction COLL Common Stock Sale $42,665 -1,804 -0.72% $23.65 249,150 27 Dec 2022 Direct F1, F3
transaction COLL Common Stock Sale $9,676 -400 -0.16% $24.19 248,750 27 Dec 2022 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022.
F2 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
F3 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
F4 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.14 to $24.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).